NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Total Return Level: 1.54 for April 5, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 05, 2024 | 1.54 |
April 04, 2024 | 1.54 |
April 03, 2024 | 1.56 |
April 02, 2024 | 1.56 |
April 01, 2024 | 1.56 |
March 28, 2024 | 1.59 |
March 27, 2024 | 1.62 |
March 26, 2024 | 1.55 |
March 25, 2024 | 1.55 |
March 22, 2024 | 1.55 |
March 21, 2024 | 1.56 |
March 20, 2024 | 1.55 |
March 19, 2024 | 1.56 |
March 18, 2024 | 1.56 |
March 15, 2024 | 1.57 |
March 14, 2024 | 1.53 |
March 13, 2024 | 1.53 |
March 12, 2024 | 1.54 |
March 11, 2024 | 1.54 |
March 08, 2024 | 1.53 |
March 07, 2024 | 1.53 |
March 06, 2024 | 1.52 |
March 05, 2024 | 1.53 |
March 04, 2024 | 1.52 |
March 01, 2024 | 1.52 |
Date | Value |
---|---|
February 29, 2024 | 1.52 |
February 28, 2024 | 1.53 |
February 27, 2024 | 1.63 |
February 26, 2024 | 1.525 |
February 23, 2024 | 1.91 |
February 22, 2024 | 1.91 |
February 21, 2024 | 1.92 |
February 20, 2024 | 1.61 |
February 16, 2024 | 1.53 |
February 15, 2024 | 1.49 |
February 14, 2024 | 1.47 |
February 13, 2024 | 1.47 |
February 12, 2024 | 1.52 |
February 09, 2024 | 1.52 |
February 08, 2024 | 1.43 |
February 07, 2024 | 1.43 |
February 06, 2024 | 1.42 |
February 05, 2024 | 1.39 |
February 02, 2024 | 1.44 |
February 01, 2024 | 1.49 |
January 31, 2024 | 1.53 |
January 30, 2024 | 1.55 |
January 29, 2024 | 1.54 |
January 26, 2024 | 1.49 |
January 25, 2024 | 1.40 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.6003
Minimum
Nov 17 2023
31.93
Maximum
Mar 17 2021
13.74
Average
15.21
Median
Feb 18 2022
Total Return Level Benchmarks
Catalent Inc | 55.25 |
AIM ImmunoTech Inc | 0.39 |
Perspective Therapeutics Inc | 1.53 |
Protalix BioTherapeutics Inc | 1.17 |
Armata Pharmaceuticals Inc | 2.65 |